Abstract:Purpose We assessed the efficiency of low-dose recombinant human bone morphogenetic protein-2 (rhBMP-2) incorporated biomimetic calcium phosphate on beta-tricalcium phosphate (beta-TCP) (rhBMP-2/BioCaP/beta-TCP) on bone formation in a model of socket preservation using cone beam computed tomography (CBCT) scanning and histological examination. Methods Forty patients undergoing minimally invasive single-root tooth extraction for dental implantation were randomized to three groups according to the material used for socket preservation: filling with rhBMP-2/BioCaP/beta-TCP, beta-TCP, or natural healing (kept unfilled) (controls). The alveolar sockets (including the control group) were covered by two-layer collagen membranes and sutured. Two CBCT scans were taken, one immediately after socket preservation procedure (baseline) and another 6 weeks later. Gray values (GVs) obtained from CBCT were recorded. During insertion of the dental implant, biopsies were taken and analyzed histologically for new bone formation, residual material, and unmineralized bone tissue at the core of the biopsy. Results The mean (+/- standard deviation) changes of GVs of the CBCT scans at the central area of filled materials were as follows: 373.19 +/- 157.16 in the rhBMP-2/BioCaP/beta-TCP group, 112.26 +/- 197.25 in the beta-TCP group, and -257 +/- 273.51 in the control group. The decrease of GVs in the rhBMP-2/BioCaP/beta-TCP group as compared with the beta-TCP group was statistically significant (P < 0.001). Differences in new bone formation (P = 0.006) were also found: 21,18% +/- 7.62% in the rhBMP-2/BioCaP/beta-TCP group, 13.44% +/- 6.03% in the beta-TCP group, and 9.49% +/- 0.08% in controls. The residual material was10.04% +/- 4.57% in the rhBMP-2/BioCaP/beta-TCP group vs. 20.60% +/- 9.54%) in the beta-TCP group (P < 0.001). Differences in unmineralized bone tissue (P < 0.001) were also found (68.78% +/- 7.67%, 65.96% +/- 12.64%, and 90.38% +/- 7.5% in the rhBMP-2/BioCaP/beta-TC, beta-TCP, and control groups, respectively). Conclusions This study shows that rhBMP-2/BioCaP/beta-TCP is a promising bone substitute with fast degradation and potent pro-osteogenic capacity that can be useful for socket preservation in implant dentistry. Trial registration: ChiCTR, ChiCTR2000035263. Registered 5 August 2020, https://www.chictr.org.cn/ChiCTR2000035263.

Low-Dose Rhbmp2/7 Heterodimer to Reconstruct Peri-Implant Bone Defects: A Micro-Ct Evaluation

Evaluation of Bone Regeneration by Β Tricalcium Phosphate/Collagen Scaffold Loaded with Bone Morphogenetic Proteins 2 Plasmid in Rat Cranial Defect

BMP2/7 heterodimer is a stronger inducer of bone regeneration in peri-implant bone defects model than BMP2 or BMP7 homodimer.

Acceleration of Bone Formation and Implant Osseointegration by BMP-2／7 Heterodimers in Vivo

Bone Regeneration of Peri-Implant Defects Using a Collagen Membrane as a Carrier for Recombinant Human Bone Morphogenetic Protein-2

Radiographic and Histological Evaluation of Bone Formation Induced by Rhbmp-2-incorporated Biomimetic Calcium Phosphate Material in Clinical Alveolar Sockets Preservation.

Addition of a Synthetically Fabricated Osteoinductive Biphasic Calcium Phosphate Bone Graft to BMP2 Improves New Bone Formation

Enhanced bone formation of rat mandibular bone defects with collagen membranes loaded on bone morphogenetic protein-9

Enhanced Effects of BMP‐binding Peptide Combined with Recombinant Human BMP‐2 on the Healing of a Rodent Segmental Femoral Defect

Repair of an intercalated long bone defect with a synthetic biodegradable bone-inducing implant

Biomechanic results of poly(lactic-co-glycolic acid)/tricalcium phosphate scaffold with bone morphogenetic protein implanted in bone defects peri-porous-titanium in rabbit femur

The effects of BMP-2 gene medication on the reconstruction of osteolytic bone defect around implant

Ectopic Osteoinduction and Early Degradation of Recombinant Human Bone Morphogenetic Protein-2-Loaded Porous Beta-Tricalcium Phosphate in Mice

Reconstruction of Peri-Implant Bone Defects Using Impacted Bone Allograft and BMP-2 Gene-Modified Bone Marrow Stromal Cells.

Repair of Rat Cranial Bone Defect by Using Bone Morphogenetic Protein-2-related Peptide Combined with Microspheres Composed of Polylactic Acid/polyglycolic Acid Copolymer and Chitosan

Implant-guided supracrestal alveolar bone growth using scaffolds, BMP-2, and novel scaffold-retaining device

Bone Morphogenetic Protein 2 Promotes Bone Formation in Bone Defects in Which Bone Remodeling Is Suppressed by Long-Term and High-Dose Zoledronic Acid

An evaluation of BMP-2 delivery from scaffolds with miniaturized dental implants in a novel rat mandible model.

Reconstruction of Mandibular Bone Defects Using Biphasic Calcium Phosphate Bone Substitutes with Simultaneous Implant Placement in Mini-Swine: A Pilot in Vivo Study.

The Influence of Recombinant Human BMP-2 on Bone–implant Osseointegration: Biomechanical Testing and Histomorphometric Analysis

Experimental study of porous beta-tricalcium phosphate and bone morphogenetic protein/porous beta-tricalcium phosphate complex in rabbit mandibular reconstruction